Gene · 29949
Papers1,818
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,818
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Plasma proteomics reveals early, broad release of chemokine, cytokine, TNF, and interferon mediators following trauma with delayed increases in a subset of chemokines and cytokines in patients that remain critically ill. | Front Immunol | 2022 | 36532045 | PubTator, text mining | PubMed |
| The roles and clinical applications of interleukins in endometrial carcinoma. | Front Oncol | 2022 | 36531027 | PubTator, text mining | PubMed |
| Immune related biomarkers for cancer metastasis to the brain. | Exp Hematol Oncol | 2022 | 36527157 | PubTator, text mining | PubMed |
| Elucidating the Gene Signatures and Immune Cell Types in HIV-Infected Immunological Non-Responders by Bioinformatics Analyses. | Int J Gen Med | 2022 | 36514742 | PubTator, text mining | PubMed |
| Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases. | Nat Commun | 2022 | 36513651 | PubTator, text mining | PubMed |
| Recent Update on the Anti-Inflammatory Activities of Propolis. | Molecules | 2022 | 36500579 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma. | J Int Med Res | 2022 | 36495170 | PubTator, text mining | PubMed |
| Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancer. | Sci Rep | 2022 | 36482068 | PubTator, text mining | PubMed |
| CD1a promotes systemic manifestations of skin inflammation. | Nat Commun | 2022 | 36477177 | PubTator, text mining | PubMed |
| Combined application of dinitrofluorobenzene and ovalbumin induced AD-like dermatitis with an increase in helper T-cell cytokines and a prolonged Th2 response. | BMC Immunol | 2022 | 36476273 | PubTator, text mining | PubMed |
| A pilot prospective prevalence study of chronic rhinosinusitis associated with inflammatory bowel disease. | World J Otorhinolaryngol Head Neck Surg | 2022 | 36474669 | PubTator, text mining | PubMed |
| Potential biomarkers of atopic dermatitis. | Front Med (Lausanne) | 2022 | 36465933 | PubTator, text mining | PubMed |
| CDX-301 prevents radiation-induced dysregulation of miRNA expression and biogenesis. | Mol Ther Nucleic Acids | 2022 | 36457703 | PubTator, text mining | PubMed |
| INPP5A/HLA-G1/IL-10/MMP-21 Axis in Progression of Esophageal Squamous Cell Carcinoma | Iran Biomed J | 2022 | 36437782 | PubTator, text mining | PubMed |
| MiRNA-374b-5p and miRNA-106a-5p are related to inflammatory bowel disease via regulating IL-10 and STAT3 signaling pathways. | BMC Gastroenterol | 2022 | 36437465 | PubTator, text mining | PubMed |
| Whole Transcriptome Analysis of Breast Cancer Tumors during Neoadjuvant Chemotherapy: Association with Hematogenous Metastasis. | Int J Mol Sci | 2022 | 36430403 | PubTator, text mining | PubMed |
| Construction of Oxidative Stress-Related Genes Risk Model Predicts the Prognosis of Uterine Corpus Endometrial Cancer Patients. | Cancers (Basel) | 2022 | 36428665 | PubTator, text mining | PubMed |
| Immune mechanisms associated with cardiovascular disease in systemic lupus erythematosus: A path to potential biomarkers. | Front Immunol | 2022 | 36420265 | PubTator, text mining | PubMed |
| Establishment and validation of evaluation models for post-inflammatory pigmentation abnormalities. | Front Immunol | 2022 | 36389813 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29949/papers?page=18